Levels of Circulating Intercellular Adhesion Molecule-1 in Patients with Metastatic Cancer of the Prostate and Benign Prostatic Hyperplasia

By Wolff J.M.   Stephenson R.N.   Chisholm G.D.   Habib F.K.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 339-341

Elsevier

Access to resources Recommend Favorite

Are We Overlooking Stage a Prostate Cancer in Patients Treated for Benign Prostatic Hyperplasia with Medical or Minimally Invasive Modalities?

By Kocurek J.N.   Orihuela E.   Neal D.E.   Pow-Sang M.   Warren M.M.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 4, 1995-07 ,pp. : 153-155

Elsevier

Access to resources Recommend Favorite

Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH

By Muecke Ralph   Klotz Theodor   Giedl Josef   Buentzel Jens   Kundt Guenther   Kisters Klaus   Prott Franz-Josef   Micke Oliver  

Acta Oncologica, Vol. 48, Iss. 3, 2009-04 ,pp. : 452-456

Informa Healthcare

Access to resources Recommend Favorite

Voltagegated sodium channels were differentially expressed in human normal prostate, benign prostatic hyperplasia and prostate cancer cells

By                  

Oncology Letters, Vol. 8, Iss. 1, 2014-01 ,pp. : 345-350

Spandidos Publications

Access to resources Recommend Favorite

Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia

By Vicentini Carlo   Gravina Giovanni   Angelucci Adriano   Pascale Esterina   D’Ambrosio Ettore   Muzi Paola   Leonardo Gabriella   Fileni Antonio   Tubaro Andrea   Festuccia Claudio   Bologna Mauro  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 4, 2004-04 ,pp. : 217-221

Springer Publishing Company

Access to resources Recommend Favorite